Teva Reports Results of Strategic Review, Sees 14 Pipeline Projects Possible for Divestment, Discontinuation
October 06, 2014 at 08:35 AM EDT
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced the results of its strategic review of core therapeutic areas for the ...